As of 2025-12-17, the Relative Valuation of Ocular Therapeutix Inc (OCUL) is (22.09) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.39 USD, the upside of Ocular Therapeutix Inc based on Relative Valuation is -253.5%.
The range of the Relative Valuation is (21.70) - (23.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.5x - 19.7x | 18.3x |
| Forward P/E multiples | 18.5x - 20.3x | 19.4x |
| Fair Price | (21.70) - (23.13) | (22.09) |
| Upside | -250.8% - -260.8% | -253.5% |
| Date | P/E |
| 2025-12-15 | -12.09 |
| 2025-12-12 | -12.42 |
| 2025-12-11 | -12.52 |
| 2025-12-10 | -13.15 |
| 2025-12-09 | -13.61 |
| 2025-12-08 | -13.75 |
| 2025-12-05 | -10.73 |
| 2025-12-04 | -10.61 |
| 2025-12-03 | -9.78 |
| 2025-12-02 | -9.60 |
| 2025-12-01 | -9.99 |
| 2025-11-28 | -10.37 |
| 2025-11-26 | -10.36 |
| 2025-11-25 | -10.35 |
| 2025-11-24 | -10.33 |
| 2025-11-21 | -10.44 |
| 2025-11-20 | -10.00 |
| 2025-11-19 | -10.33 |
| 2025-11-18 | -10.03 |
| 2025-11-17 | -10.15 |
| 2025-11-14 | -9.64 |
| 2025-11-13 | -9.55 |
| 2025-11-12 | -9.80 |
| 2025-11-11 | -9.57 |
| 2025-11-10 | -9.24 |
| 2025-11-07 | -9.26 |
| 2025-11-06 | -9.07 |
| 2025-11-05 | -9.22 |
| 2025-11-04 | -9.30 |
| 2025-11-03 | -9.74 |
| 2025-10-31 | -9.95 |
| 2025-10-30 | -10.09 |
| 2025-10-29 | -9.80 |
| 2025-10-28 | -9.84 |
| 2025-10-27 | -9.86 |
| 2025-10-24 | -9.80 |
| 2025-10-23 | -9.76 |
| 2025-10-22 | -9.68 |
| 2025-10-21 | -10.04 |
| 2025-10-20 | -10.39 |
| 2025-10-17 | -10.10 |
| 2025-10-16 | -10.41 |
| 2025-10-15 | -10.18 |
| 2025-10-14 | -9.58 |
| 2025-10-13 | -10.11 |
| 2025-10-10 | -10.05 |
| 2025-10-09 | -10.19 |
| 2025-10-08 | -10.16 |
| 2025-10-07 | -9.83 |
| 2025-10-06 | -9.36 |